A detailed history of Quent Capital, LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Quent Capital, LLC holds 949 shares of DCTH stock, worth $10,780. This represents 0.0% of its overall portfolio holdings.

Number of Shares
949
Previous 949 -0.0%
Holding current value
$10,780
Previous $7,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$4.47 - $8.37 $1,922 - $3,599
430 Added 82.85%
949 $7,000
Q4 2023

Jun 14, 2024

BUY
$2.25 - $4.17 $94 - $175
42 Added 8.81%
519 $2,000
Q4 2023

Jan 19, 2024

BUY
$2.25 - $4.17 $94 - $175
42 Added 8.81%
519 $2,000
Q3 2023

Jun 14, 2024

BUY
$3.12 - $5.85 $489 - $918
157 Added 49.06%
477 $1,000
Q3 2023

Oct 10, 2023

BUY
$3.12 - $5.85 $489 - $918
157 Added 49.06%
477 $1,000
Q2 2023

Jun 14, 2024

SELL
$5.38 - $7.96 $1,070 - $1,584
-199 Reduced 38.34%
320 $1,000
Q2 2023

Jul 10, 2023

BUY
$5.38 - $7.96 $1,721 - $2,547
320 New
320 $1,000

Others Institutions Holding DCTH

About DELCATH SYSTEMS, INC.


  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $97.7M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.